Adenosquamous Carcinoma and Pure Squamous Cell Carcinoma of the Pancreas: Report of two Cases.

A 69-year-old woman was admitted to our hospital with abdominal pain and jaundice. Imaging modalities including CT, MRI and ERCP revealed a tumor in the head of the pancreas. Pancreaticoduodenal resection and cholecystectomy were performed. Grossly, an infiltrative solid tumor measuring 5 × 5 × 6 cm was recognized. Histologically, the tumor is pure SCC (fig. 2a ). The SCC was moderately differentiated SCC with keratinization (fig. 2b ) and intercellular bridges (fig. 2c ). Many perineural invasions and lymphovascular permeations were present. The tumor cells invaded the extrahepatic bile duct, duodenum and peripancreatic fat tissue and involved peripancreatic lymph nodes. The patient died of systemic metastasis three months after operation.

Adenosquamous carcinoma (ASC) of the pancreas is very rare, its incidence being 3–4% of all pancreatic malignancies [ 1 ]. ASC of the pancreas has been sporadically reported as case reports, and there are several comprehensive reports of a relatively large series [ 2 , 3 , 4 , 5 ]. Squamous cell carcinoma (SCC) of the pancreas is a much rarer disease. A few case reports have been published [ 6 , 7 , 8 , 9 ], but there are no comprehensive studies of large series. The author reports herein one case of ASC and one case of pure SCC of the pancreas.

According to the WHO classification [ 10 ], ASC is defined as a rare pancreatic neoplasm characterized by the presence of a variable proportion of mucin-producing glandular elements and squamous components. The squamous component should account for at least 30% of the tumor tissue. Our case 1 fulfills these criteria. ASC of the pancreas is a rare tumor with an incidence of 3-4% of all pancreatic malignancies [ 1 , 10 ]. This neoplasm is an aggressive tumor with a poor prognosis. The mean prognosis period is about six months [ 1 , 2 , 4 ]; it is shorter than for ordinary ductal adenocarcinoma of the pancreas [ 10 ]. The most involved site is the pancreatic head, followed by the body and tail [ 4 ]. In the present case of ASC, the prognosis was five months, and the ASC was present in the body of the pancreas. The pathogenesis of ASC is unclear. Two theories exist: (1) the squamous element is derived from squamous transdifferentiation of adenocarcinoma element; (2) the ASC of the pancreas arises from pluripotent stem cells. In our case, the adenocarcinoma and squamous elements were mixed up, and a gradual transition was recognized between the two. SSC of the pancreas is much rarer than ASC. The exact incidence is unknown. There are a few case reports of SCC of the pancreas [ 6 , 7 , 8 , 9 ], but no comprehensive reports of large series. This entity is not listed in the WHO book [ 10 ]. An analysis of the four cases reported previously [ 6 , 7 , 8 , 9 ] shows that SCC is an aggressive tumor with a poor prognosis, like ASC of the pancreas. In the present SCC of the pancreas, the prognosis was only three months. The pathogenesis of SCC of the pancreas is unknown. The author speculates that SCC of the pancreas may be derived from malignant transformation of squamous metaplasia of pancreatic ducts, or may arise from pluripotent stem cells in the pancreas.